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Abstract
 
The glycoxidation products N
 
e
 
-(carboxymethyl)lysine and
pentosidine increase in skin collagen with age and at an ac-
celerated rate in diabetes. Their age-adjusted concentrations
in skin collagen are correlated with the severity of diabetic
complications. To determine the relative roles of increased
glycation and/or oxidation in the accelerated formation of
glycoxidation products in diabetes, we measured levels of
amino acid oxidation products, distinct from glycoxidative
modifications of amino acids, as independent indicators of
oxidative stress and damage to collagen in aging and diabe-
tes. We show that 
 
ortho
 
-tyrosine and methionine sulfoxide
are formed in concert with N
 
e
 
-(carboxymethyl)lysine and pen-
tosidine during glycoxidation of collagen in vitro, and that
they also increase with age in human skin collagen. The age-
adjusted levels of these oxidized amino acids in collagen
was the same in diabetic and nondiabetic subjects, arguing
that diabetes per se does not cause an increase in oxidative
stress or damage to extracellular matrix proteins. These re-
sults provide evidence for an age-dependent increase in oxi-
dative damage to collagen and support previous conclusions
that the increase in glycoxidation products in skin collagen
in diabetes can be explained by the increase in glycemia
alone, without invoking a generalized, diabetes-dependent
increase in oxidative stress. (
 
J. Clin. Invest. 
 
1997. 100:839–
846.) Key words: advanced glycation end-products 
 
•
 
 carboxy-
methyllysine 
 
•
 
 glycation 
 
•
 
 oxidation 
 
•
 
 pentosidine
 
Introduction
 
Advanced glycation end-products (AGEs),
 
1
 
 formed by nonen-
zymatic Maillard reactions between carbohydrates and pro-
teins, contribute to the age-dependent increase in chemical
modification and cross-linking of long lived tissue proteins (1,
2). Increased glycation of proteins and formation of AGEs are
also implicated in the pathogenesis of the long term complica-
tions of diabetes (3–5). N
 
e
 
-(carboxymethyl)lysine (CML) and
pentosidine are frequently used chemical biomarkers of AGE
formation in tissues, and both of these compounds increase in
proteins with age in skin collagen and at an accelerated rate in
diabetes (6, 7). Because they are formed in reactions of pro-
teins with glucose only under oxidative conditions, they have
been termed glycoxidation products (1). Based on the increase
in age-adjusted levels of CML and pentosidine in diabetic col-
lagen, Dyer et al. (7) concluded that diabetes may be consid-
ered, at least at the chemical level, as a disease characterized
by accelerated aging of tissue collagens by advanced glycation
and oxidation reactions. However, the relative importance of
increased glycation and/or oxidation in the formation of AGEs
in diabetes has not been rigorously evaluated. 
Both blood glucose and protein glycation are increased and
have been identified as potential sources of oxidative stress
(i.e., increased production of reactive oxidant species [ROS])
in diabetes (8, 9). Thus, hyperglycemia may simultaneously en-
hance both glycative and oxidative stress, and the increase in
glycation and oxidation chemistry may contribute synergisti-
cally to the formation of AGEs and development of diabetic
complications (10). Still, despite growing evidence of increased
oxidative stress in diabetes (11), Dyer et al. (7) concluded that
the age-corrected levels of glycoxidation products in skin col-
lagen of diabetic patients could be explained solely by the du-
ration of diabetes and the long term increase in blood glucose
concentration, as measured by glycation of hemoglobin or col-
lagen, without invoking an increase in oxidative stress in dia-
betes. However, their conclusion is based on the assumption
that AGEs are derived only from glucose or glycated proteins
and is compromised by uncertainties regarding the actual ori-
gin of glycoxidation products. Thus, not only glucose but also
ascorbate, pentoses, and other carbohydrates may form both
CML and pentosidine (12, 13), and recent work indicates that
CML may also be formed from products of lipid peroxidation,
independent of glycoxidation reactions (14). 
To obtain an independent assessment of the status of oxi-
dative stress in diabetes, we set out to determine if non–carbo-
hydrate-derived amino acid oxidation products were formed
during glycoxidation of protein in vitro and, if so, whether the
levels of these products were also increased in human skin col-
lagen from diabetic compared with age-matched nondiabetic
individuals. We reasoned that age-adjusted levels of oxidized
amino acids would provide an index of oxidative stress and
damage to extracellular protein, structurally distinct from gly-
coxidative modification of amino acids. The two products on
which we focused represent a range of susceptibility of amino
acids to oxidation: methionine sulfoxide (MetSO), which is
formed readily and in significant yield under mild oxidizing con-
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1. 
 
Abbreviations used in this paper:
 
 AGE, advanced glycation end-
product; CML, N
 
e
 
-(carboxymethyl)lysine; FL, N
 
e
 
-(1-deoxy-
 
d
 
-fructos-
1-yl)lysine (fructoselysine); MetSO, methionine sulfoxide; 
 
o
 
-Tyr,
 
ortho
 
-tyrosine; ROS, reactive oxygen species.
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ditions (15, 16), and 
 
ortho
 
-tyrosine (
 
o
 
-Tyr), which is formed in
low yield during metal-catalyzed and radiolytic oxidation of pro-
teins (17, 18). We show here that both MetSO and 
 
o
 
-Tyr are
formed in concert with CML and pentosidine during glycation
of collagen under oxidative conditions in vitro. We also show
that both MetSO and 
 
o
 
-Tyr increase normally with age in hu-
man skin collagen, providing evidence of an age-dependent in-
crease in oxidative damage to collagen, independent of forma-
tion of glycoxidation products. However, levels of MetSO and
 
o
 
-Tyr were not increased in skin collagen from diabetic com-
pared with nondiabetic subjects, arguing that there is not a sys-
temic increase in oxidative stress in the extracellular matrix in
diabetes. 
 
Methods
 
Materials.
 
Reagents were purchased from Sigma Chemical Co. (St.
Louis, MO) or Aldrich Chemical Co. (Milwaukee, WI) unless other-
wise indicated. Internal standards [
 
13
 
C
 
6
 
]-fructoselysine (FL) and
[
 
2
 
H
 
8
 
]-CML were prepared as described previously (19). [
 
13
 
C
 
6
 
]-Phe (99
atom%) was purchased from Cambridge Isotope Laboratories
(Woburn, MA), and [
 
13
 
C
 
6
 
]-
 
o-
 
Tyr was synthesized from [
 
13
 
C
 
6
 
]-Phe as
described previously for [
 
2
 
H
 
4
 
]-
 
o-
 
Tyr (15).
 
In vitro incubations.
 
Rat tail collagen was prepared from 150–200 g
rats and incubated with glucose in 200 mM phosphate buffer, pH 7.4,
under oxidative or antioxidative conditions at 37
 
8
 
C, as described pre-
viously (20, 21). Oxidative incubations were conducted under aerobic
conditions, and antioxidative incubations under a nitrogen (anaero-
bic) atmosphere in buffer containing 1-mM concentrations of diethyl-
enetriaminepentaacetic acid and phytic acid to chelate transition
metal catalysts of oxidation chemistry. To completely inhibit oxida-
tive chemistry during long term antioxidative reactions, the solutions
were thoroughly degassed under vacuum, replenished with nitrogen,
and then incubated in a tissue culture incubator under nitrogen. Oth-
erwise, methionine sulfoxide, a sensitive indicator of oxidative chem-
istry was sometimes detected in antioxidative reaction mixtures. Indi-
vidual vials were set up for each time point and frozen at 
 
2
 
20
 
8
 
C until
analysis.
 
Patient samples. 
 
Human skin collagen samples were obtained
from nondiabetic and diabetic donors or at autopsy at the Royal Vic-
toria Hospital. The protocol was approved by the Institutional Re-
view Board for use of Human Subjects. Samples were processed as
described previously (7) and stored at 
 
2
 
70
 
8
 
C until analysis. Measure-
ments of 
 
o
 
-Tyr in human skin collagen were performed using samples
from 23 subjects without diabetes, aged 0–85 yr, and 17 subjects with
insulin-dependent diabetes mellitus, aged 17–58 yr. Duration of dia-
betes was 14.4
 
6
 
10.7 yr. Glycated hemoglobin (percent HbA
 
1
 
), mea-
sured by agar gel electrophoresis (Corning Medical, Halsted, UK) was
10.4
 
6
 
1.8; the percent HbA
 
1
 
 range for a nondiabetic reference popu-
lation was 3.6
 
2
 
7.2%. Because of limited amounts of samples, mea-
surements of MetSO were performed on a subset of 17 subjects with-
out diabetes, aged 2–85 yr, and 12 subjects with insulin-dependent
diabetes mellitus, aged 19–58 yr. For this group, duration of diabetes
was 14.8–11.2 yr, and percent HbA
 
1
 
 was 10.7–1.6.
 
Gas chromatography–mass spectrometry analyses. 
 
Electron impact
ionization–selected ion monitoring–gas chromatography–mass spec-
trometry analyses were performed on a 5890 gas chromatograph–5970
mass selective detector system (Hewlett-Packard Co., Palo Alto, CA)
(7), with the exception of 
 
o
 
-Tyr in human skin collagen (see below),
which was performed on a double focusing magnetic sector mass
spectrometer (VG 70SQ; Fisons Instruments, Altrincham, UK). All
analyses were performed using a 30-m Rtx
 
®
 
-5 capillary column
(Restek Corp., Bellefonte, PA). Peak areas of each analyte were nor-
malized to their respective, heavy labeled internal standard, and quan-
titation was based on calibration curves generated using increasing
amounts of each analyte and constant amounts of internal standards.
To normalize for the amount of protein analyzed, final values of gly-
cation, glycoxidation, and oxidation products were expressed as a ra-
tio to their precursor amino acids, Lys, 
 
o
 
-Tyr or Met, respectively.
 
Measurement of FL, CML, and pentosidine. 
 
These compounds
were analyzed after hydrolysis of collagen, as described previously
(22). FL was measured as the N,O-trifluoroacetyl trifluoroethyl ester
derivative of its hydrolysis product, furosine. CML was measured in
NaBH
 
4
 
-reduced samples as the N-trifluoroacetyl trifluoroethyl ester
derivative. Pentosidine was measured in NaBH
 
4
 
-reduced samples by
reverse phase–HPLC with fluorescence detection (Ex 
 
5 
 
328 nm; Em 
 
5
 
378 nm). 
 
Measurement of o-Tyr. 
 
Internal standards for 
 
o-
 
Tyr and Phe
(0.05 nmol [
 
13
 
C
 
6
 
]-
 
o-
 
Tyr and 130 nmol [
 
13
 
C
 
6
 
]-Phe) were added to unre-
duced samples before hydrolysis. After hydrolysis under N
 
2
 
 in 6
 
 
 
N
HCl for 24 h at 110
 
8
 
C, Phe and 
 
o-
 
Tyr were measured by selected ion
monitoring–gas chromatography–mass spectrometry as their acetyl
isopropyl ester derivatives, as described previously (15). For rat tail
collagen samples, the 265 and 271 ions were monitored for 
 
o-
 
Tyr and
[
 
13
 
C
 
6
 
]-
 
o-
 
Tyr, respectively, and the 249 and 255 ions were monitored
for Phe and [
 
13
 
C
 
6
 
]-Phe, respectively. To increase sensitivity and speci-
ficity for measurement of 
 
o
 
-Tyr in human skin collagen, these sam-
ples were analyzed by high resolution mass spectrometry, monitoring
the 265.1314 and 271.1515 ions for 
 
o-
 
Tyr and [
 
13
 
C
 
6
 
]-
 
o-
 
Tyr, respec-
tively. Because of the sample requirement for measurement of 
 
o
 
-Tyr,
the signal from the M
 
1
 
 ions of Phe and 
 
13
 
C
 
6
 
-Phe (249.1365 and
255.1566, respectively) exceeded the dynamic range of the data sys-
tem. Therefore, the natural abundance [
 
13
 
C] ions of the M
 
1
 
 ions of
Phe and [
 
13
 
C
 
6
 
]-Phe (250.1398 and 256.1600, respectively) were moni-
tored for measurement of Phe, resulting in an 85–90% reduction in
peak areas. The following temperature program was used: 2 min at
100
 
8
 
C, ramp at 5
 
8
 
C/min to 260
 
8
 
C, ramp at 15
 
8
 
C/min to 290
 
8
 
C, hold at
290
 
8
 
C for 3 min.
 
Measurement of MetSO. 
 
MetSO was measured as methionine af-
ter two sequential cyanogen bromide treatments of unreduced col-
lagen (21). Samples were hydrolyzed as above, except that dithiothre-
itol (5 mM) was included to ensure complete conversion of MetSO to
Met during hydrolysis. Met, homoserine, and homoserine lactone
were measured by amino acid analysis using cation exchange chroma-
tography and postcolumn fluorescence detection with 
 
o
 
-phthaldialde-
hyde (23). The MetSO content of collagen is expressed relative to its
total Met 
 
1 
 
MetSO content.
 
Data analysis. 
 
Statistical analyses were performed by the Spear-
man Rank Correlation method for nonparametric data using Sigma-
Stat (Jandel Scientific, San Rafael, CA), and by Spearman-Rank Par-
tial Correlations using SAS
 
®
 
 (SAS Institute Inc., Cary, NC) to correct
for correlation with age. A value of
 
 P 
 
# 
 
0.05 was judged statistically
significant.
 
Results
 
Kinetics of formation of glycation, glycoxidation and oxidation
products during glycation of collagen in vitro. 
 
Collagen was
incubated for various times (0–5 wk) in the presence of 250
mM glucose in 200 mM phosphate buffer, pH 7.4, at 37
 
8
 
C un-
der oxidative or antioxidative conditions. The Amadori adduct
FL was measured to determine the extent of glycation of the
protein. CML and pentosidine were measured as indicators of
glycoxidation, and MetSO and 
 
o
 
-Tyr as indices of oxidative
damage to the amino acid backbone of the protein, as well as
overall oxidative stress in the reaction system. The kinetics of
formation of FL, CML, and pentosidine were consistent with
those of previous studies (20, 21). Thus, initial rates of forma-
tion of FL (Fig. 1 
 
A
 
) were comparable under oxidative and an-
tioxidative conditions, but higher yields of FL were obtained at
3–5 wk under antioxidative conditions. Recent work suggests
that these differences result from the more rapid rate of degra-
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dation of FL to CML and other products under oxidative con-
ditions (24). CML and pentosidine were formed only under
oxidative conditions, but at significantly different rates, yield-
ing a CML/pentosidine concentration ratio of 
 
z 
 
50 at 5 wk
(Fig. 1 
 
B
 
). For comparison, the relative CML/pentosidine con-
centrations in human skin collagen are 
 
z 
 
40 (7). 
Like the glycoxidation products,
 
 
 
MetSO and 
 
o
 
-Tyr were
formed only under oxidative conditions, and their concentra-
tions increased with time of incubation of collagen with glu-
cose (Fig. 1 
 
C
 
). At 5 wk, 
 
o
 
-Tyr accounted for 
 
z 
 
0.2% of the
Phe content of the collagen. MetSO was a more sensitive indi-
cator of oxidative damage, accounting for 
 
. 
 
50% of the origi-
nal Met in collagen at 5 wk. A background level of endogenous
MetSO was also detected in the starting rat tail collagen, as in
human skin collagen (see below). The rate of formation of
MetSO was 
 
z 
 
300
 
3 
 
that of 
 
o
 
-Tyr (Fig. 1 
 
C
 
).
To determine the effect of glucose concentration on the
formation of MetSO and 
 
o
 
-Tyr, collagen was incubated for 5 wk
with various concentrations of glucose under oxidative or anti-
oxidative conditions. The glucose concentration was varied
from normoglycemic (5 mM) and hyperglycemic (25 mM) con-
centrations to higher concentrations commonly employed in
in vitro model systems to accelerate AGE formation. As
observed previously (19, 20), the yield of FL increased with
glucose concentration and was 25–30% higher under antioxi-
dative compared with oxidative conditions (Fig. 2 
 
A
 
). Glycoxi-
dation products (Fig. 2 
 
B
 
) and amino acid oxidation products
(Fig. 2 
 
C
 
) were formed only under oxidative conditions. Nei-
ther glycoxidation products nor MetSO or 
 
o-
 
Tyr increased
during a 5-wk incubation under antioxidative conditions in the
absence of glucose. (Compare levels of oxidation products in
sample at zero time in Fig. 1 
 
C
 
 with 5-wk incubation at zero
glucose concentration in Fig. 2 
 
C
 
). Effects of glucose concen-
Figure 1. Kinetics of formation of (A) fructoselysine, (B) CML and 
pentosidine, and (C) MetSO and o-Tyr during glycation of collagen in 
vitro under oxidative and antioxidative conditions. Collagen was in-
cubated in the presence of 250 mM glucose in 200 mM phosphate 
buffer, pH 7.4, at 378C under oxidative or antioxidative conditions. 
Samples were removed at the indicated times for analysis. Results 
shown in this figure are from a single experiment, representative of at 
least three independent studies and measurements. Note that the ver-
tical axes of the various plots differ significantly in scale.
Figure 2. Effect of glucose concentration on formation of (A) fruc-
toselysine, (B) CML and pentosidine, and (C) MetSO and o-Tyr dur-
ing glycation of collagen in vitro under oxidative and antioxidative 
conditions. Collagen was incubated with indicated concentrations of 
glucose under conditions described in Fig. 1 and analyzed after reac-
tion for 5 wk. Results shown in this figure are from a single experi-
ment, representative of at least three independent studies and mea-
surements. Note that the vertical axes of the various plots differ 
significantly in scale.
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tration on formation of MetSO and o-Tyr closely paralleled
effects on formation of glycoxidation products in these incuba-
tions, including the trend to a plateau at higher glucose con-
centrations. This plateau might result from inhibition of metal-
catalyzed autoxidation reactions by the antioxidant and metal
chelating activities of products formed during the late stages of
the Maillard reaction (25). The ratios of CML/pentosidine and
MetSO/o-Tyr were relatively independent of glucose concen-
tration and similar to those observed in Fig. 1. Notably, both
MetSO and o-Tyr were readily detected in collagen incubated
with 5 mM glucose and increased two- to threefold in collagen
incubated in 25 mM glucose, suggesting that they should be
useful as carbohydrate-independent biomarkers for assessing the
status of oxidative stress in vivo under hyperglycemic com-
pared with normoglycemic conditions. As shown below, how-
ever, although levels of MetSO and o-Tyr increased with age
in skin collagen, their age-adjusted levels were not increased in
diabetes, suggesting that increased oxidative stress does not
contribute to the increase in glycoxidation of collagen in dia-
betes.
Measurement of MetSO and o-Tyr in human skin collagen.
As shown in Fig. 3, there was a strong correlation between
both the MetSO and o-Tyr content of skin collagen and donor
age for nondiabetic subjects. Linear least squares analysis of
the line for the nondiabetic population (Fig. 3) indicated that
MetSO and o-Tyr increased approximately three- to fourfold
in skin collagen between ages 10 and 80 yr. In previous studies
(7), we had observed approximately sevenfold increases in
CML and pentosidine during the same age range. As shown in
Fig. 4, there were no differences in levels of MetSO between
the diabetic and control groups (Fig. 4 A, two-sided P 5 0.92
for combined sample size of 22) nor in levels of o-Tyr in skin
collagen from a group of diabetic patients, compared with age-
matched control subjects (Fig. 4 B, two-sided P 5 0.36 for the
combined sample size of 30). The magnitude of the P values
and the lack of significance for both MetSO and o-Tyr support
the conclusion that there is no difference in age-adjusted levels
of MetSO and o-Tyr in skin collagen from diabetic compared
with control subjects. Simulated t and P values for double and
triple the sample sizes were also calculated by sample size in-
crease simulation using the current trend and variance and
were also nonsignificant, supporting the strength of the conclu-
sions. As shown in Fig. 5, the levels of MetSO and o-Tyr also
correlated strongly with one another in both groups. For both
diabetic and control subjects, levels of MetSO in human skin
collagen were z 6,000–8,0003 higher than those of o-Tyr, sig-
nificantly greater than the ratios observed in collagen glycoxi-
dized in vitro (z 300; Figs. 1 C and 2 C). The difference in ra-
Figure 3. Concentrations of MetSO and o-Tyr in human skin col-
lagen as a function of age. MetSO (top). The equation of the linear 
regression line is: mmol MetSO/mol Met 5 1.1 3 age 1 34 (n 5 17, 
r 5 0.72, P 5 0.001). o-Tyr (bottom). The equation of the linear re-
gression line is: mmol o-Tyr/mol Phe 5 0.17 3 age 1 2.3 (n 5 23, r 5 
0.85, P , 0.001). Lines drawn are linear least-squares fit to the data. 
Statistical analyses were performed by Spearman Rank Correlation.
Figure 4. Age-dependent increase in MetSO and o-Tyr in human 
skin collagen from diabetic and nondiabetic subjects. MetSO (top). 
The equation of the line for the nondiabetic samples (solid line and 
symbols) is: mmol MetSO/mol Met 5 1.6 3 age 1 20.7 (n 5 10,
r 5 0.67, P 5 0.04); the equation of the line for the diabetic samples 
(dashed line, s) is mmol MetSO/mol Met 5 1.8 3 age 1 13.2 (n 5 12, 
r 5 0.86, P , 0.001). o-Tyr (bottom). The equation of the line for the 
nondiabetic samples (solid line, d) is mmol o-Tyr/mol Phe 5 0.88 3 
age 1 1.2 (n 5 13, r 5 0.81, P , 0.001); the equation of the line for 
the diabetic samples (dashed line, s) is mmol o-Tyr/mol Phe 5 
0.85 3 age 1 4.6 (n 5 17, r 5 0.76, P , 0.001). The lines drawn are 
linear least squares fits to the data. Statistical analyses were per-
formed by Spearman Rank Correlation.
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tios between the in vivo and in vitro systems probably results
from differences in the nature or relative concentrations of
ROS in the two systems. 
The concentrations of the various oxidation and glycoxida-
tion products in collagen correlated with one another in both
the diabetic and nondiabetic populations, with r values ranging
from 0.68–0.85 and P values ranging from 0.008 to , 0.0001 for
the various comparisons (Table I). Partial correlation analyses,
correcting for the effect of age, are summarized in Table II. In
this case, for comparison with the diabetic samples, correla-
tions were calculated for both the total group of nondiabetic
samples and separately for those nondiabetic samples that
spanned the same age range as the diabetic samples. After cor-
rection for effects of age, there were still significant partial cor-
relations of MetSO and o-Tyr with both CML and pentosidine
in the nondiabetic population, but not in the diabetic popula-
tion. Overall, there were strong correlations between oxida-
tion and glycoxidation products in human skin collagen, and
age-corrected partial correlations remained significant in the
nondiabetic group, but not in the diabetic group.
Discussion
Oxidative stress in diabetes. In this study, we have demon-
strated that two biomarkers of oxidative stress and damage to
protein, MetSO and o-Tyr, increase in concert with the glycox-
idation products, CML and pentosidine, during glycation of
collagen under oxidative conditions in vitro. These results doc-
ument that oxidative damage to amino acids in proteins occurs
during glycoxidation reactions, probably as a result of superox-
ide and H2O2 formation during metal-catalyzed glycoxidation
reactions (26, 27). In other work (20, 21), we have shown that
the increase in glycoxidation products during glycation of col-
lagen under oxidative conditions is accompanied by the forma-
tion of fluorescent products and the cross-linking of collagen.
Similar changes in levels of glycoxidation products, AGE-like
fluorescence and cross-linking occur naturally with age in col-
lagen in vivo, and we demonstrate here that these changes are
also accompanied by age-dependent increases in both MetSO
and o-Tyr in human skin collagen. Partial correlations, inde-
pendent of age, between levels of MetSO and o-Tyr and levels
of CML and pentosidine in collagen were statistically signifi-
cant in nondiabetic subjects (Table II), suggesting that levels
of both oxidation and glycoxidation products were affected by
a similar background level or set point of oxidative stress. The
loss of partial correlations between oxidation and glycoxida-
tion products in the diabetic population is consistent with a dis-
sociation between rates of oxidation and glycoxidation in these
patients, possibly resulting from effects of variations in glyce-
mic control, protein glycation, and duration of disease on the
rate of formation of glycoxidation products among diabetic pa-
tients.
The significant partial correlations between levels of amino
acid oxidation and glycoxidation products in skin collagen from
nondiabetic subjects and the loss of this correlation in the col-
lagen from diabetic patients (Table II), and the observation
that age-corrected levels of MetSO and o-Tyr in skin collagen
were not increased in diabetic compared with nondiabetic sub-
jects (Figs. 4 and 5) argue strongly that there is not a systemic
or generalized increase in oxidative stress in diabetes, at least
in the extracellular compartment. These results support the
conclusion of Dyer et al. (7) that the increase in glycoxidation
products in human skin collagen in diabetes can be explained
by the increase in glycemia during the course of diabetes, with-
out invoking a diabetes-dependent increase in oxidative stress.
Dyer et al. (7) also proposed, however, that patients with com-
parable levels of hyperglycemia and duration of diabetes, but
with higher set points for oxidative stress, may be at increased
risk for development of complications. Like hereditary suscep-
Figure 5. Comparison 
of concentrations of 
MetSO and o-Tyr in hu-
man skin collagen from 
nondiabetic (s) and di-
abetic (d) subjects. 
The lines drawn are lin-
ear least squares fits to 
the data for the nondia-
betic (solid line) and di-
abetic (dashed line) 
samples. Statistical 
analyses by Spearman 
Rank Correlation were 
nondiabetic, n 5 16, 
r 5 0.94, P , 0.001; diabetic, n 5 12, r 5 0.64, P 5 0.025; total group, 
n 5 30, r 5 0.86, P , 0.001. 
Table I. Correlations between Oxidation and Glycoxidation 
Products in Human Skin Collagen
CML Pentosidine
Nondiabetic Diabetic Nondiabetic Diabetic
o-Tyr
r 0.82 0.72 0.68 0.81
P , 0.0001 0.004 0.008 0.0001
n 21 14 18 14
MetSO
r 0.73 0.82 0.85 0.84
P 0.0007 0.007 0.0003 0.001
n 17 9 13 11
Table II. Age-corrected Correlations between Oxidation and 
Glycoxidation Products in Human Skin Collagen
Correlated products Nondiabetic Nondiabetic Diabetic
0–82 yr 17–58 yr 17–58 yr
o-Tyr « CML r 5 0.55 r 5 0.53 r 5 0.11
P 5 0.01 P 5 0.08 P 5 0.74
n 5 21 n 5 13 n 5 14
o-Tyr « pentosidine r 5 0.58 r 5 0.60 r 5 0.16
P 5 0.01 P 5 0.054 P 5 0.61
n 5 18 n 5 13 n 5 14
MetSO « CML r 5 0.54 r 5 0.53 r 5 0.16
P 5 0.03 P 5 0.14 P 5 0.71
n 5 17 n 5 10 n 5 9
MetSO « pentosidine r 5 0.72 r 5 0.77 r 5 0.48
P 5 0.009 P 5 0.03 P 5 0.16
n 5 13 n 5 9 n 5 11
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tibility to hypertension or hyperlipidemia, differences in genet-
ically determined set points for oxidative stress may still be an
important factor determining individual risk for development
of complications. These issues could not be addressed in the
present study because of the limited number of samples avail-
able and the range of complications status among the patients
studied, but will be addressed in future research. 
Although we have concluded from our studies that oxida-
tive stress is not generally increased in the extracellular milieu
in diabetes, there is considerable experimental and clinical evi-
dence implicating increased oxidative stress in the develop-
ment of diabetic complications (reviewed in references 1, 8–10,
28–33). For example, antioxidant vitamins, drugs, and thiol
compounds have retarded the development of retinopathy
(34), neuropathy (35, 36), and vasculopathy (37) in the strepto-
zotocin-induced diabetic rat model. However, the diabetic rat
is frequently a severe, chronically ketoacidotic model for the
study of diabetic complications, and these animals commonly
fail to increase in weight or even suffer severe weight loss as a
result of muscle wasting during the course of experiments. Ob-
servations made in this model may not always be relevant to
understanding the pathogenesis of complications developing
more gradually in less extreme human diabetes (38). On the
other hand, deficits in ascorbate and glutathione homeostasis
are well documented in human diabetes (reviewed in refer-
ences 1, 28, 30), suggesting that, independent of observations
in animal models, antioxidant defenses may be compromised
in human diabetes. These apparent contradictions are not
readily resolved, but it should be recognized that increases in
oxidative stress may be associated with the complications and
tissue damage, rather than with diabetes per se. Thus, levels of
AGEs in collagen (7) and in plasma are significantly higher in
diabetic patients with renal disease, compared with those with
normal renal function, but are also increased in nondiabetic
patients with renal disease (39, 40), suggesting that nephropa-
thy, rather than diabetes, may be the more significant determi-
nant of oxidative stress and the rate of glycoxidation reactions
in vivo. 
Threshold effects may also be important in explaining why
oxidative stress is not increased in diabetes; i.e., even with
measurable decreases in antioxidant defenses in human diabe-
tes, these defenses may still be sufficient to limit increased glu-
cose or lipid dependent oxidative damage to tissue proteins.
Thus, the increase in glycoxidation products (CML and pento-
sidine), but not oxidation products (MetSO and o-Tyr), in dia-
betes suggests that oxidative defenses are adequate—that the
threshold has not been exceeded. The increase in glycoxida-
tion products, and possibly similar products derived from lipid
peroxidation, may be viewed as the result of increased levels of
oxidizable substrates (i.e., carbohydrates or lipids) rather than
increased background levels of ROS. In the scheme shown in
Fig. 6, oxidative stress may be represented by the steady state
level of ROS ([O2]*), the balance between the rates of genera-
tion (k1) and detoxification (k2) of reactive oxygen. An in-
crease in an oxidizable substrate, such as glucose, may lead to
increased substrate-dependent oxidative damage (glycoxida-
tion products) with a substrate-specific rate constant (k3). The
substrate-dependent increase in glycoxidation of collagen in
diabetes could occur without a change in oxidative stress
[O2]*, and the rate of oxidative modification of the protein
backbone, which is dependent on [O2]* and assessed by levels
of MetSO and o-Tyr, would not be altered. 
A limitation of our studies is the focus on skin collagen,
which may not be an appropriate sensor for intracellular oxi-
dative stress in other tissues. Indeed, skin is not a major site of
pathology in diabetes, and collagen is an extracellular matrix
protein. It is possible that oxidative stress may be increased
specifically within cells, for example, as a result of altered glu-
cose metabolism during hyperglycemia (reviewed in refer-
ences 10, 28, 41), by the action of AGEs bound to cell surface
receptors (42), or by other mechanisms and that there may be
tissue-specific variations in levels of antioxidant vitamins and
enzymes, glutathione, and other cofactors (43, 44). However,
there are strong correlations between levels of glycoxidation
products in skin collagen and the severity of diabetic retinal,
renal, and vascular disease (3–5), and cellular membranes are
freely permeable to ROS, such as O2H• (the protonated form
of superoxide, pKa z 4.5) and H2O2. Resolution of these prob-
lems will require studies of other indicators of oxidative stress
in diabetes, such as protein carbonyls (45), lipid peroxidation
products (14, 46), and amino acid oxidation products in cellu-
lar proteins. A more comprehensive study of age-adjusted lev-
els of MetSO and o-Tyr in skin collagen from diabetic patients
with similar age of onset, duration of disease, and long-term
glycemic control, but with significant differences in status of
complications, should provide a clearer insight into the rela-
tionship between oxidative stress and the development of dia-
betic complications.
Oxidative stress and aging. In addition to identification of
MetSO and o-Tyr as indicators of oxidative damage to tissue
proteins, our results provide chemical evidence, consistent
with the free radical theory of aging (47). According to this
theory, aging is the result of cumulative oxidative damage to
biomolecules. The increase in glycoxidation products and
amino acid oxidation products in skin collagen provides evi-
dence for an age-dependent increase in oxidative damage, al-
Figure 6. Relationship 
between rates of oxi-
dant generation, antiox-
idant activity, oxidative 
stress (OxS), and oxida-
tive damage. [O2]* rep-
resents various forms 
of reactive oxygen (e.g., 
hydroxyl radical, super-
oxide, and hydroperoxy 
radical, or metal–oxy-
gen complexes) gener-
ated with an overall rate 
constant k1 and detoxi-
fied with an overall rate 
constant k2 by a variety 
of enzymatic and nonenzymatic mechanisms. Oxidative stress (OxS) 
may be considered a measure of the steady state level of [O2]*. Reac-
tion of [O2]* with a variety of biomolecule substrates, such as carbo-
hydrates, lipids, proteins, and nucleic acids, with varying rate con-
stants k3 depending on the substrate, leads to formation of oxidation 
products in tissues. The overall rate of formation of oxidation prod-
ucts (Oxidative Damage) depends on ambient levels of both substrate 
and [O2]*. Oxidatively damaged proteins may also be catabolized and 
replaced during turnover processes (k4), thus the steady state level of 
oxidative damage in tissues is affected by a range of substrate concen-
trations and rate constants.
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though it does not establish a causal relationship between oxi-
dative stress and aging. The relationship between levels of
amino acid oxidation products in skin collagen and species life
span is also unknown. However, these issues can be addressed
experimentally by measuring the rates of increase in MetSO
and o-Tyr in collagen from species of varying life spans and by
evaluating the effects of caloric restriction, which extends max-
imum life span in numerous species (48), on the rate of in-
crease in MetSO and o-Tyr in collagen. Measurements of these
relatively stable amino acid oxidation products should provide
a direct indicator of oxidative damage and would not be com-
promised by changes in glycemia and protein glycation. 
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